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Capsule endoscopy (CE) enables evaluation of the entire mucosal surface of the small bowel (SB), which is one of the most important 
steps for evaluating obscure gastrointestinal bleeding. Although the diagnostic yield of SB CE depends on many clinical factors, 
there are no reports on quality indicators. Thus, the Korean Gut Image Study Group (KGISG) publishes an article titled, “Quality 
Indicators for Small Bowel Capsule Endoscopy” under approval from the Korean Society of Gastrointestinal Endoscopy (KSGE). 
Herein, we initially identified process quality indicators, while the structural and outcome indicators are reserved until sufficient 
clinical data are accumulated. We believe that outcomes of SB CE can be improved by trying to meet our proposed quality indicators. 
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INTRODUCTION
Capsule endoscopy (CE) was introduced in 20001 and since 
then, it has become one of the first-line diagnostic tools for 
small bowel (SB) disorders.2 Currently more than 4000 stud-
ies addressing CE can be found using PubMed. Additionally, 
applications of CE have been expanded to the evaluation of 
esophageal and colorectal disorders. 
CE is the best method to evaluate the entire mucosal sur-
face of the SB and it plays a key role in evaluation of obscure 
gastrointestinal bleeding (OGIB). However, the diagnostic 
yield of SB CE can be affected by many factors, such as indi-
cations, bowel preparation, technical errors, view mode and 
frame rate during interpretation, reviewers’ experience, and 
so on. 
Diagnostic procedures with inadequate quality may be 
related with decreased diagnostic accuracy, procedure-relat-
ed complications, and unnecessary medical burden. How-
ever, there are no publications on quality indicators for SB 
CE. Thus, the members of Korean Gut Image Study Group 
(KGISG) decided to establish “Quality Indicators for Small 
Bowel Capsule Endoscopy” under approval from the Korean 
Society of Gastrointestinal Endoscopy (KSGE). 
Generally, quality indicators refer to specific issues iden-
tified for comparison and potential improvement3 and they 
represent a minimally acceptable standard of care.4 Quality in-
dicators are classified as structural, process and outcome mea-
sures based on the type of assessment. Structural indicators 
evaluate the health care environment and they are typically 
scrutinized during accreditation surveys. Process indicators 
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represent care delivery performance and outcome indicators 
suggest results of care.3 Herein we describe process indicators. 
Structural and outcome indicators have not been covered 
in this article since there are insufficient clinical studies and 
evidences regarding the standards of care environments and 
minimal requirements for care results. 
We believe the following quality indicators will be helpful 
to establish competence of CE and to improve quality of CE.
METHODS
Three taskforce teams (preprocedure, intraprocedure, and 
postprocedure) from KGISG were formed and each team 
performed systematic literature search and prepared a com-
prehensive review to identify articles relevant to CE since the 
year 2000, using PubMed, MEDLINE, KoreaMed, and Google 
Scholar. Each team generated indicator candidates. Finally, 16 
quality indicators were selected after repetitive discussions. 
Each candidate indicator, proposed by a team, was reviewed 
and discussed by other teams in a crossover manner. The 
grades of recommendation were classified in Table 1 based on 
levels of evidence.5,6 The proposed preprocedural, intraproce-
dural, and postprocedural quality indicators common to SB 
CE are listed in Table 2.
PREPROCEDURAL QUALITY 
INDICATORS
Indications
OGIB
Capsule endoscopy is recommended as the first-line inves-
tigation for patients with obscure gastrointestinal bleeding 
(grade of recommendation: 1A).
The overall diagnostic yield of CE for OGIB ranges between 
30% and 70%, which is higher than that of other diagnostic 
modalities (push enteroscopy, double-balloon enteroscopy 
[DBE], and SB series with sensitivities of 31%, 23%, and 5%, 
respectively).7-9 CE should be performed as soon as possi-
ble after the bleeding episode, optimally within 14 days, to 
maximize the diagnostic yield.7 The causative lesions include 
intestinal angiodysplasia, SB ulcer, blood in the SB without an 
Table 1. Grade of Recommendation
Grade of recom-
mendation Clarity of benefit Methodologic strength supporting evidence Implications
1A Clear Randomized trials without important limita-
tions
Strong recommendation, can be applied 
to most clinical settings
1B Clear Randomized trials with important limitations 
(inconsistent results, nonfatal methodologic 
flaws) 
Strong recommendation, likely to apply to 
most practice settings
1C+ Clear Overwhelming evidence from observational 
studies
Strong recommendation, can apply to 
most practice settings in most situations
1C Clear Observational studies Intermediate-strength recommendation, 
may change when stronger evidence is 
available
2A Unclear Randomized trials without important limita-
tions
Intermediate-strength recommendation, 
best action may differ depending on 
circumstances or patients ’ or societal 
values
2B Unclear Randomized trials with important limitations 
(inconsistent results, nonfatal methodologic 
flaws)
Weak recommendation, alternative ap-
proaches may be better under some 
circumstances
2C Unclear Observational studies Very weak recommendation, alternative 
approaches likely to be better under 
some circumstances
3 Unclear Expert opinion only Weak recommendation, likely to change 
as data become available
Adapted from Guyatt et al.5 
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identified lesion, SB tumors, and SB varices.9,10 From about a 
half to two thirds of patients receiving non-steroidal anti-in-
flammatory drugs (NSAIDs) have SB lesions such as erosions, 
petechiae, denudated mucosa, bleeding lesions, ulcers, and 
etc.11 The role of CE is clearer in patients with OGIB after neg-
ative results of conventional endoscopy. Iron deficiency ane-
Table 2. Summary of Proposed Quality Indicators Common to Small Bowel Capsule Endoscopy
Quality indicator Grade of recommendation
Measure 
type
Preprocedural 
Capsule endoscopy is recommended as the first-line investigation for patients with obscure gastro-
intestinal bleeding.
1A Process
Capsule endoscopy is the most sensitive diagnostic modality for detecting mucosal lesions of the 
small bowel in patients with suspected or established Crohn’s disease.
1B Process
Capsule endoscopy is useful for detection of small bowel tumors and polyps. 2C Process
In patients with Crohn’s disease, previous abdominal surgery, intestinal ischemia, volvulus, and 
history of abdominal radiotherapy, the risk of capsule retention is increased. For risk stratification 
and prevention of capsule retention, taking careful clinical history and performing careful physi-
cal examination is essential.
3 Process
In subjects with Crohn’s disease, obstructive symptoms, and suspicious stenosis, small bowel imag-
ing, such as computed tomography enterography or magnetic resonance enterography, should be 
methods of choice for patency of small bowel prior to subsequent capsule endoscopy. Additional-
ly, the use of patency capsule to confirm functional patency of the small bowel is recommended.
2C Process
Intraprocedural and postprocedural patient instructions should be provided in written form before 
performing small bowel capsule endoscopy.
3 Process
Intraprocedural
Excellent or good preparation (>75% small bowel visualization) is considered to enhance diagnos-
tic yield of small bowel examination.
1C Process
Bowel preparation with purgatives enhances the small bowel visual quality compared with fasting 
alone or a clear liquid diet.
1B Process
Photodocumentation of capsule passing through the ileocecal valve or into the colon is necessary 
for verification of entire small bowel exploration.
2C Process
When capsule endoscopy is performed in patients with high risk of delayed gastric emptying, 
identifying capsule’s position using plain radiography or real-time viewer after ingestion, or en-
doscopic employment of capsule endoscopy is recommended.
1B Process
Technical errors during capsule endoscopy procedure can decrease quality of the capsule endosco-
py image, although, it seldom occurs.
3 Process
Postprocedural 
DualView or QuadView may be recommended as the viewing mode to improve reading efficiency 
and detection rate of interpreters reading capsule endoscopy.
2C Process
During capsule endoscopy reading, 15 frames per second or less is appropriate for acceptable de-
tection rate.
2C Process
Experience with minimum of 10–20 capsule endoscopy cases is required for trainees to attain cap-
sule endoscopy competency. Because the lesion miss rate during capsule endoscopy is relatively 
high, interpretation of findings in capsule endoscopy should be done by experienced and compe-
tent endoscopists. Interpretation performed by a trainee should be reviewed and confirmed by an 
expert.
1C and 2C Process
Either conservative or endoscopic treatment can be considered for capsule retention, and the de-
cision depends on patient’s symptoms or availability of enteroscopy. Surgical removal of retained 
capsule could be reserved for asymptomatic patients.
3 Process
Procedure reports are required for every capsule endoscopy and should be accurate, concise, and 
completed in a timely manner.
3 Process
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mia (IDA) is usually determined based on blood loss through 
the gastrointestinal (GI) tract. Therefore, CE is a good method 
to identify causative lesions once other common potential 
bleeding sources located within the reach of conventional 
endoscopies have been excluded. Additionally, CE is useful in 
determining the route of device-assisted enteroscopy (DAE).
Crohn’s disease 
Capsule endoscopy is the most sensitive diagnostic modal-
ity for detecting mucosal lesions of the small bowel in pa-
tients with suspected or established Crohn’s disease (grade 
of recommendation: 1B).
CE plays a role in diagnosing suspected Crohn’s disease (CD) 
when the clinical history is compatible, but not as much as di-
agnostic ileocolonoscopy. SB endoscopy helps to make differ-
ential diagnosis of CD in suspected CD patients by identifying 
SB involvement proximal to the terminal ileum. It also plays a 
role in the mucosal severity of the SB and disease extension in 
patients with established CD.7,12-14 Meta-analysis showed that 
the diagnostic yield for SB CD was higher (50%–70%) with 
CE than with other diagnostic modalities (SB series, 22%; 
colonoscopy, 48%; push enteroscopy, 8%; and enteroclysis/
computed tomography enterography [CTE], 31%).12 When 
stenosis or obstruction is suspected, patency capsule or careful 
examination using cross-sectional imaging modalities, such as 
magnetic resonance (MR)/CT, should be considered first.
SB tumor and polyposis syndrome
Capsule endoscopy is useful for detection of small bowel 
tumors and polyps (grade of recommendation: 2C).
CE is recommended for patients with OGIB to find SB 
tumor. However, DAE is preferred rather than CE in patients 
with SB tumor-suspected images.7 The most common pre-
sentation of SB tumors is OGIB and the most common histo-
pathological type of these tumors is adenocarcinoma, followed 
by carcinoid tumors, lymphoma, sarcoma, and hamartoma. 
The most common location is the jejunum (40%–60%), fol-
lowed by the ileum (25%–40%) and duodenum (15%–25%).10 
CE is also useful in detection of SB polyps and surveillance 
in familial adenomatous polyposis and Peutz-Jeghers syn-
drome.7,15
Celiac disease
The use of CE for suspected celiac disease is not routinely 
recommended. However, it is suggested to use CE in patients 
unwilling or unable to undergo conventional endoscopy.7
Abdominal pain of unknown origin
CE has a low diagnostic yield in patients with abdominal 
pain (13%); however, the diagnostic yield of CE can be im-
proved in patients with chronic abdominal pain accompanied 
with elevated serum inflammatory markers (C-reactive pro-
tein, erythrocyte sedimentation rate), weight loss, diarrhea, 
and so on.16
Identifying high-risk patients for capsule retention
In patients with Crohn’s disease, previous abdominal sur-
gery, intestinal ischemia, volvulus, and history of abdomi-
nal radiotherapy, the risk of capsule retention is increased. 
For risk stratification and prevention of capsule retention, 
taking careful clinical history and performing careful 
physical examination is essential (grade of recommenda-
tion: 3).
The capsule is usually excreted with feces within 24–48 
hours of ingestion. Capsule retention (CR) is defined as hav-
ing a capsule remain in the GI tract for more than 2 weeks or 
requiring directed surgical or endoscopic intervention.17 The 
known rate of CR is almost 0% in healthy adults, 13% in pa-
tients with suspected or known CD, and 16% in patients with 
symptomatic SB obstruction.18
In cases of CD, up to 66% of patients have SB involvement 
at diagnosis. Twenty-five percent of patients with CD have 
had at least one SB stricture.19 Data from the hospital-based 
study with 16-year follow-up period showed that the stricture 
occurred in 20.1% of CD cases.20 Other known risk factors 
associated with CR are NSAIDs enteropathy, previous ab-
dominal surgery, intestinal ischemia, volvulus, and history of 
abdominal radiotherapy.17
In subjects with Crohn’s disease, obstructive symptoms, 
and suspicious stenosis, small bowel imaging, such as com-
puted tomography enterography or magnetic resonance 
enterography, should be methods of choice for patency of 
small bowel prior to subsequent capsule endoscopy. Ad-
ditionally, the use of patency capsule to confirm the func-
tional patency of small bowel is recommended (grade of 
recommendation: 2C).
Since CTE/CT enteroclysis or MR enterography (MRE)/MR 
enteroclysis could identify strictures and assess the transmural 
or extraluminal nature of the disease, if subjects have obstruc-
tive symptoms or suspicious stenosis, dedicated SB cross-sec-
tional imaging with CTE or MRE generally takes precedence 
over CE for evaluation of the SB.7,21 In CD, the findings of SB 
stenosis at CTE or MRE may preclude prior to CE in 27% 
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to 40%.22 In the studies using patency capsule instead of CE, 
MRE has a high negative predictive values (96.3%–100%) and 
sensitivity (92.3%–100%) for patency CR.23 
Patency capsule is used before CE to evaluate the patency 
of the GI tract in patients with stricture or suspected stric-
ture.17 According to a study comparing CR rates in high risk 
patients evaluated with patency capsule and SB cross-sectional 
imaging, it was more predictable for high risk patients with 
negative patency capsule to have negative CR than for those 
who received SB cross-sectional imaging.24 CE following pos-
itive patency capsule in patients with CD was associated with 
a high risk of CR. However, the risk of CR was not reduced by 
nonselective use of the patency capsule.25 Recently, novel radio 
frequency identification (RFID) tag-less patency capsule has 
been introduced to clinical practice to reduce associated risks 
of the typical patency capsule. The impact of the patency cap-
sule’s inner RFID tag in a stricture could cause SB ileus. Use 
of the tag-less patency capsule can confirm GI tract patency 
in most of the patients who did not have stenosis during im-
aging and allowed estimation of the patency for patients who 
did have stenosis on imaging.26
Patient instructions
Intraprocedural and postprocedural patient instructions 
should be provided in written form before performing 
small bowel capsule endoscopy (grade of recommenda-
tion: 3).
Little is known about whether the diagnostic yield or 
quality of CE can be influenced by the intraprocedural and 
postprocedural patient instructions. In general, the manufac-
turer’s guidelines include the acceptable physical activity and 
dietary intake after swallowing the capsule to ensure success-
ful tests.27,28 Early clinical studies related to CE also specifically 
described the instructions to the patients after capsule inges-
tion.29,30 These instructions mainly include recommendations 
related to physical activity and acceptable dietary intake while 
tests are proceeding. In addition, patients should be instruct-
ed about when they should return data recorders or suspect 
the possibility of CR after completion of tests. Details of 
general instructions are summarized in Supplementary Ta-
bles 1 and 2. If needed, individualized instructions could be 
provided or ordered by the physicians. For example, dietary 
intake should be restricted for the patient with ongoing overt 
OGIB who may require urgent or emergent intervention 
based on the results of CE.
INTRAPROCEDURAL QUALITY 
INDICATORS
Bowel preparation
Quality of adequate bowel preparation
Excellent or good preparation (>75% small bowel visual-
ization) is considered to enhance diagnostic yield of small 
bowel examination (grade of recommendation: 1C).
During CE, several factors, such as bubbles, food material 
in the SB, and gastric and SB transit time, influence the SB 
visualization quality (SBVQ), diagnostic yield, and cecal com-
pletion rate were analyzed. Therefore, bowel preparation prior 
to CE is as important as bowel preparation prior to colonos-
copy. Diagnostic yield is defined as a meaningful diagnostic 
finding of CE. Purgative bowel preparations enhance diagnos-
tic yield of SB examination using CE.31 
SBVQ was defined as follows: “excellent,” if an ideal visu-
alization of the SB mucosa was achieved (>90%); “good,” if 
>75% of the mucosa was in perfect condition; “fair,” if only 
50%–75% of the mucosa was under perfect conditions; and 
“poor,” if <50% of the mucosa could be observed. However, 
there was no consensus of optimal bowel preparation for CE, 
as each study with polyethylene glycol (PEG) suggested var-
ious definitions for bowel preparation quality. A recent study 
considered excellent or good preparation (>75% SB visualiza-
tion) as an adequate bowel preparation.32
Purgatives of adequate bowel preparation
Bowel preparation with purgatives enhances the small 
bowel visual quality compared with fasting alone or a clear 
liquid diet (grade of recommendation: 1B).
To date, there have been many comparative studies, consen-
sus, and guidelines regarding different types of bowel cleans-
ing agents in bowel preparation for CE.33 Currently, PEG-
based regimens are primarily recommended. A 2-L PEG with 
simethicone is most frequently recommended for CE bowel 
preparation. Sodium picosulphate-based regimens are recom-
mended as a second option, as their cleansing efficacy is less 
than that of PEG-based regimens. 
According to the guidelines for bowel preparation, which 
were published by the KGISG in 2013,34 bowel preparation 
with PEG compared with fasting alone or clear liquid diet 
enhances diagnostic yield and SBVQ without effect on cecal 
completion rate. A 2-L PEG solution for bowel preparation 
is similar to that of a 4-L PEG solution in diagnostic yield, 
   153 
Shim KN et al. Quality Indicators for Capsule Endoscopy
SBVQ, and cecal completion rate of CE.35,36 Bowel preparation 
by fasting or administration of PEG solution, when combined 
with simethicone, enhances SBVQ, but does not affect cecal 
completion rate of CE.37-40 Bowel preparation using prokinet-
ics does not enhance SBVQ, diagnostic yield, or cecal comple-
tion rate of CE.34
Currently, there has been no consensus regarding optimal 
timing of bowel preparation before CE. A 2-L PEG-based 
purge, administered one day prior, is the most commonly 
used preparation method. In clinical practice, CE exam is 
followed by colonoscopy in patients with obscure GI bleeding 
or CD. Therefore, the timing of bowel preparation is fre-
quently dependent on the time of colonoscopic examination. 
According to a single center study by Black et al.,41 there was 
no significant difference of diagnostic yield, and the quality 
according to timing of SB preparation (14 hours vs. 4 hours 
prior to the CE). The day before bowel preparation showed 
similar results to the same-day bowel preparation regarding 
quality, SB transit time, cecal completion rate, and overall di-
agnostic yield. Considering colonoscopic bowel preparation, 
shorter time interval between bowel preparation and CE may 
result in superior visualization. Further study is required for 
clarification.
Completion rate
Photodocumentation of capsule passing through the ile-
ocecal valve or into the colon is necessary for verification 
of entire small bowel exploration (grade of recommenda-
tion: 2C).
Although CE is a useful tool for evaluating SB disease, it 
is impossible to visualize the entire SB in all patients because 
capsules have not always passed through the ileocecal valve 
before battery exhaustion due to various reasons.42 
Complete examination was defined as capsule passing 
through the ileocecal valve or into the colon on images during 
its working time.42 To increase diagnosis yield, complete ex-
amination rate of the entire SB is important.
The incomplete examination rate of the CE based on the 10-
year data from the Korean CE registry was 33% (969/2,914).43 
Multiple logistic regression analysis indicated that completion 
rates were significantly higher with better bowel preparation 
and in patients with OGIB. The incomplete rate was signifi-
cantly higher in elderly patients. 
Hospitalization, history of SB surgery, and delayed gastric 
emptying had been shown to be risk factors for incomplete 
examination.44 Effort to increase complete examination rate is 
important in order to maximize the diagnostic yield of CE.
When capsule endoscopy is performed in patients with 
high risk of delayed gastric emptying, identifying capsule’s 
position using plain radiography or real-time viewer after 
ingestion, or endoscopic employment of capsule endosco-
py is recommended (grade of recommendation: 1B).
Gastric retention resulting in capsule failing to enter the 
duodenum and delayed gastric transit, remaining in the stom-
ach for more than 1–1.5 hours had been known as the major 
causes for incomplete examination.45 
The effects of routine use of prokinetics, such as metoclo-
pramide and erythromycin, to enhance gastric transit were 
inconsistent.46-50
Identifying capsule’s position using plain radiography or 
real-time viewer two hours after ingestion is recommended as 
the effective method to reduce gastric transit time, especially 
in patients who are more likely to have delayed gastric tran-
sit. Particularly, use of external real-time viewer to check the 
progress of the capsule and prespecified actions, such as ad-
ditional water swallowing, administration of prokinetics, and 
endoscopic delivery, significantly improved the completion 
rate.51-53
Although it is invasive, endoscopic delivery of capsule to 
the duodenum has been used as an optimal method to reduce 
gastric transit time. Additionally, it can be useful in patients 
with high risk of delayed gastric emptying, particularly in 
patients with diabetes, vagotomy, scleroderma, or ongoing 
hospitalization.53-55
Technical errors
Technical errors during capsule endoscopy procedure can 
decrease quality of capsule endoscopy images, although, it 
seldom occurs (grade of recommendation: 3).
CE image is of significant importance, because high-qual-
ity images provide more information for diagnosis. It is not 
satisfactory mainly because of factors that reduce CE quality. 
Images obtained during CE are exposed to different types of 
noise; for example, food and gas in the stomach, SB, or colon 
can reduce image quality. Captured images tend to have tech-
nical errors.56 
Together, results of previous studies allow technical errors 
to be divided into two types: CE system-related error (com-
munication and transmission error) and patient-related error. 
CE system-related errors include low resolution, blurred 
images, and light-related distortions. One of the typical noise 
types in the capsule image was due to data communication 
errors.57 The CE image quality can be improved by removing 
noise using a median filter or a smart antenna technique, 
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based on the results of these studies.58 Patient-related technical 
errors in CE images can occur in patients with implantable 
cardiac devices (ICD). The presence of an ICD is one of the 
relative contraindications for CE. CE interference may arise 
during the procedure, resulting in alterations of the ICD.59 
However, few studies show actual interference between the 
ICD and CE.60 Left ventricular assist devices (LVADs) had the 
tendency to interfere with CE image capture; therefore, a po-
sitioning the CE lead as far away from the LVAD as possible 
was required.61,62 Recently, interference-related problems be-
tween CE and LVADs are expected to be solved by replacing 
the lead sensor with a sensor belt. 
Hence, CE image quality plays a critical role in diagnosis. 
Although there are no published reports of the technical er-
ror rate in practice, it is generally considered to be very low. 
However, because technical errors during the CE procedure 
are associated with quality of the CE image, these need to be 
reported more carefully. Based on these results, action should 
be taken to solve or reduce technical errors for better quality 
CE images.
POSTPROCEDURAL QUALITY 
INDICATORS
Interpretation
View mode
DualView or QuadView may be recommended as the 
viewing mode to improve reading efficiency and detection 
rate of interpreters reading capsule endoscopy (grade of 
recommendation: 2C).
To date, there is no optimal view mode for the best inter-
pretation of CE. However, the appropriate selection image 
number at the monitor improves reading efficiency and de-
tection rate of interpreters reading CE.63 Currently, softwares 
for CE reading have several view mode options, including 
SingleView, DualView, and QuadView, according to the num-
ber of images shown in one monitor.64 In a survey including 
530 members of the American College of Gastroenterology, 
SingleView, DualView, and QuadView were used by 23.7%, 
40.4%, and 54.5%, respectively.65 QuadView has a theoretical 
advantage of longer single frame exposure time compared to 
SingleView, helping interpreters in detecting more lesions.63,66 
However, QuadView might have a drawback of making read-
ers rely on their peripheral vision because of simultaneous 
focusing on several images.66
A previous study evaluated the effect on the SB using 10 
selected video clips. The playing time from the entry of the 
capsule into the duodenal bulb to the cecum, without the 
video being stopped once started, was determined by 11 dif-
ferent combinations of video mode and frame rates in order 
to evaluate the impact of view mode on reading time and 
detection rates of lesions. There was no difference in reading 
time according to view mode at the same frame rate.63 How-
ever, detection rate was higher in DualView or QuadView 
than in SingleView: 56% in SingleView, 83% in DualView, and 
85% in QuadView at 10 frames per second (f.p.s). There was 
no significant difference in detection rates between DualView 
and QuadView regardless of frame rates. Therefore, DualView 
or QuadView may be recommended for the selection of view 
mode during CE reading because of higher detection rates 
compared to SingleView. Because it has not been determined 
whether the appropriate view mode for the highest detection 
rate during CE reading is DualView or QuadView, interpret-
ers can select one of these view modes based on their prefer-
ence.
Frame rate
During capsule endoscopy reading, 15 frames per second 
or less is appropriate for acceptable detection rate (grade of 
recommendation: 2C).
The frame rate means the number of f.p.s that is displayed 
in a video file by softwares for CE reading. Currently, these 
softwares provide a various range of frame rates allowing re-
duction of reading time of thousands of capsule’s images.64 In 
a study evaluating the effect of frame rate on reading time and 
detection rate, slower frame rate increased reading time irre-
spective of view mode options: compared to 10 f.p.s, the mean 
playing time of videos shortened by 33%, 61%, and 72% in 15, 
25, and 40 f.p.s, respectively.63 In contrast, when interpreters 
were asked to manually count angioectasia of each positive 
image from video clips, detection rates calculated using max-
imum number of positive images were 75% in 10 f.p.s, 51% in 
15 f.p.s, and 36% in 25 f.p.s. There was a significant difference 
in detection rates according to frame rates. In a study evalu-
ating detection rates among different options based on view 
mode and frame rates, detection rates were 45% in SingleView 
15 f.p.s, 26% in SingleView 25 f.p.s, 47% in QuadView 20 f.p.s, 
and 43% in QuadView 30 f.p.s.66 These studies suggest that 
slower frame rates can result in higher detection rates during 
CE reading despite the need for longer reading time. 
According to a panel consensus of 2002 International 
Conference of Capsule Endoscopy, the fastest acceptable 
frame rate of review was 15 f.p.s.67 However, the consensus 
was made by experienced interpreters in CE reading and the 
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frame rate option could have been determined based on their 
own experience. Actually, a previous study suggested that 
trainees should begin using the frame rates of 5–10 f.p.s for 
optimal interpretation.68 Based on these results, 15 f.p.s or less 
(combined with DualView or QuadView) is recommended 
for appropriate frame rate during CE reading. Although, the 
optimal frame rate for acceptable detection rate and reading 
time is unclear. Further studies are needed to determine the 
best option for appropriate interpretation based on view mode 
and frame rate in real practice, considering the experience of 
interpreters and the optimal lower limit of detection rates.
Reviewer
Experience with minimum of 10–20 capsule endoscopy 
cases is required for trainees to attain capsule endoscopy 
competency (grade of recommendation: 1C).
Because the lesion miss rate during capsule endoscopy 
is relative high, interpretation of findings in capsule en-
doscopy should be done by experienced and competent 
endoscopists. Interpretation performed by a trainee should 
be reviewed and confirmed by an expert (grade of recom-
mendation: 2C).
The utility of CE as a diagnostic tool depends on the accu-
racy of interpretation. However, lesion miss rate is high pos-
sibly because only a small fraction of images shows clinically 
significant lesions during the reading of capsule images.66 The 
miss rate in CE reading was reported to be 11% of all SB find-
ings and 18.9% for single-mass lesions.69 The American Society 
of Gastrointestinal Endoscopy recommended that interpre-
tation of CE should be performed by endoscopists who com-
pleted a GI endoscopy training program for the diagnosis and 
management of small intestinal disease.70 However, there is no 
data addressing issues regarding standardized competency as-
sessment tools and minimum training requirements to ensure 
competence for CE. Although published guidelines including 
American Gastroenterological Association, American Society 
of Gastrointestinal Endoscopy, and KSGE have recommended 
25, 20, and 10 cases of CE, respectively as necessary to ensure 
competence in the interpretation of findings,70-72 these rec-
ommendations are made based mainly on societal guidelines 
and expert opinions. Recently, two prospective studies have 
investigated issues regarding CE learning curves.73,74 One sin-
gle-center prospective study investigated 39 GI fellows based 
on structured CE training curriculum.73 In this study, fellows 
were grouped according to the number of completed CE 
interpretations. Mean scores for trainees with fewer than 10, 
11 to 20, and 21 to 35 CE interpretations were 79%, 79%, and 
85%, respectively. A significant difference was seen between 
staff and fellow scores with 10 or fewer and 11 to 20 interpre-
tations, respectively (p<0.001). Furthermore, no correlation 
was observed between CE test scores of trainee and previous 
endoscopy experience. Another Korean multicenter study 
also evaluated the number of cases needed for trainees to gain 
necessary experience for CE competency.74 Most of the mean 
kappa coefficients were >0.60 and >0.80 after week 9 and 11, 
respectively, which indicates a good agreement of the trainees 
with the expert after 9 weeks and a very good agreement after 
11 weeks. In this study, approximately 10 cases of CE were 
suggested as a minimum number of CE required for trainees 
to attain competency. Taken together, learning curve of CE 
interpretation seems to include 10–20 cases of CE for a trainee 
who has competency in wired endoscopy. During this period, 
continuous guidance and feedback under proper supervision 
is warranted. 
However, the effect of interpreter’s experience on detection 
of lesions during CE reading has not been fully determined. A 
recent study including 17 endoscopists with experience from 
23 to over 1,000 total CE procedures showed that experience 
of capsule reading did not significantly affect detection rate: 
17% of the interpreters with the lowest detection rates had 
reading experience of more than 300 capsules.66 Although we 
cannot confirm the effect of experience on detection of the 
lesion, the inter-observer variability in CE reading is differ-
ent according to the amount of experience. Several studies 
showed that the inter-observer variability was higher among 
non-experienced endoscopists.75-77 There has been no study 
about the additional benefit of interpretation by two experts; 
however, in a case of a trainee, a review made by an expert is 
essential for the improvement of interpretation quality.
Complications
Either conservative or endoscopic treatment can be con-
sidered for capsule retention, and the decision depends on 
patient’s symptoms or availability of enteroscopy. Surgical 
removal of retained capsule could be reserved for asymp-
tomatic patients (grade of recommendation: 3).
CE has been proved to be an effective and safe device in 
the diagnosis of SB disease with few complications or adverse 
effects. Retention of capsule, perforation, aspiration, and SB 
obstruction are reported as complications of CE. Among 
these, CR is the most common complication. Retained cap-
sules are usually asymptomatic but may cause partial or 
complete intestinal SB obstruction in some patients. Several 
cases where a CR leads to intestinal perforation have been re-
ported.78,79 A systemic review by Liao et al. stated that among 
the 164 retained capsules reported in 122 articles, most were 
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Table 3. Korean Standard of Capsule Endoscopy Report
Korean Standard of Capsule Endoscopy Report
  1. Institute or Hospital:
  2. Patient: 
 Name:
 Age/Sex: 
 Hospital registration No:
  3. Date of study: (d)/(m)/(yr)
  4. CE company:  Given
   IntroMedic (MiroCam)
   Olympus
   Others
  5. CE type: SB/esophagus/colon/stomach
  6. Doctor:  Ordered by Dr.                
   Interpreted by Dr.                
  7. History
 i) Medical history: none/diabetes mellitus/thyroid disease/hypertension/tuberculosis/renal disease/liver disease/surgery/others:
 ii) Recent drug history: none/NSAID/aspirin/steroid/anticoagulant/others:
  8. Clinical indications for CE
 i) Symptom: abdominal pain/chronic diarrhea/weight loss/melena
 ii) Sign: anemia/obscure GI bleeding, overt/obscure GI bleeding, occult/protein-losing enteropathy
 iii)  Diseases: CD/ulcerative colitis/intestinal tuberculosis/polyposis/intestinal tumor or mass/intestinal ischemia/Celiac sprue/Behçet 
disease/lymphoma
 iv) Others
  9. Contraindications for CE
	 i)	 	Known	or	suspected	GI	obstruction,	stricture,	or	fistulas	based	on	the	clinical	picture	or	pre-procedure	testing	(CT	or	MRE,	pa-
tency capsule, SB series)
	 ii)	 Pediatrics	(less	than	9	years)
 iii) Swallowing disorder
 iv) Pregnancy
 v) Others
10. Onset of chief complaints: days/months/years ago
11. Studies done before CE
 i) None
	 ii)	 	Choose	multiple	if	performed:	EGD/colonoscopy/US/CT/SB	series/push	enteroscopy/DBE/MRI/angiography/PET/others
 iii) Result of pre-CE studies: 
  negative
  suspiciously positive
  positive, compatible with CE
  positive, independently with CE
12. Characteristics of CE examination
 i)  Preparation technique: NPO only/PEG 4 L/PEG 2 L/Fleet/simethicone
 ii)  Use of prokinetics: none/metoclopramide/erythromycin/mosapride/domperidone/alaxyl/others
 iii) Preparation quality: excellent/adequate/inadequate, but exam completed/inadequate, precluding exam
 iv)  Visualization quality: excellent/inadequate illumination/inadequate preparation
	 v)		Type	of	equipment	malfunction:	none/capsule/recorder/others
 vi) Endoscopic delivery into duodenum: yes/no
13. Extent of examination
 i)  Total battery time:
 ii)  Stomach transit time:
 iii)  SB transit time:
 iv)  The furthest identifiable anatomic site: esophagus/stomach/jejunum/ileum/ileocecal valve/right colon/left colon/rectum
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surgically removed (58.7%, 108/164).42 However, according to 
the full texts of 128 articles, of the 104 retained capsules with 
clinical symptoms mentioned, 88 were asymptomatic and 
only 16 were associated with partial or complete intestinal ob-
struction.42 In the case series presented by Höög et al., surgical 
removal was performed in 27 out of 31 patients with CR.80 
However, only 9 of 27 patients showed obstructive symptoms. 
Moreover, there were postoperative deaths in 3 of the 27 cases, 
2 due to anastomotic breakdown and 1 due to multi-organ 
failure.80 Considering post-operative complications, decision 
of surgical removal should be made very carefully. Recent 
studies showed more favorable results with conservative man-
agement, such as treating the underlying disease, in patients 
with CD, with corticosteroids or anti-tumor necrosis factor 
(TNF) antibodies, and cessation of NSAIDs in patients with 
drug-induced enteropathy. Such conservative management 
induced spontaneous passage of the capsule in 52.4% of cas-
es.81 The longest duration of a case with CR was 6 years and 
10 months, which had been asymptomatic. During follow 
up period, there was also no breakdown of CE. In the case 
series by Höög et al., one patient who received anti-TNF 
therapy showed CR due to a CD.80 He then expelled capsule 
2.5 years later.80,82 Such cases suggest that conservative or 
medical management may be a good option in patients with 
asymptomatic CR. However, a case of disruption of retained 
CE after 3 years was also reported. Therefore, a possibility 
of CE disruption should be informed during “wait and see” 
strategy period. Another option is endoscopic removal using 
DBE or single-balloon enteroscopy. Recent study reported 
treatment strategy for CR by DBE. Their result revealed that 
72.7% (32/44) of retained CE could be successfully retrieved 
by enteroscopy.83 Among 12 cases with unsuccessful removal 
by enteroscopy, spontaneous passage of retained capsule after 
medication therapy was observed in 11.4% (5/44) of patients, 
only 6.8% (3/44) needed surgery. Abovementioned results 
suggested the feasibility of enteroscopic removal of retained 
capsule and clarified the factors associated with successful 
removal (jejunal location, antegrade insertion, three or fewer 
strictures). Abovementioned results also showed successful 
conservative and endoscopic management of CR. Based on 
these reports, if there are no symptoms associated with CR, 
conservative or endoscopic treatment can be considered, and 
Table 3. Continued
Korean Standard of Capsule Endoscopy Report
14. Complication: none/CE retention/aspiration
 i) If retention occurred,
  Site: esophagus/stomach/jejunum/ileum
  Cause: gastroparesis/gut stenosis/others/unknown
  Outcome: spontaneous pass-out/medical/endoscopic removal/surgical removal/observation still now
  Day of elimination: days
 ii) If aspiration occurred,
  Treatment: none/endoscopic removal/surgical removal
15. Findings
 i) Major:
 ii) Minor:
 iii) Minor:
16. Diagnostic impression
 i)                                                   
 ii) Level of certainty: established of/suspicious of/exclusion of/follow up of in addition,
17. Studies done after CE
 None/EGD/colonoscopy/US/SB series/push enteroscopy/DBE or single balloon enteroscopy/CT/MRI/angiography/PET/others
 Result of post-CE studies: negative/suspiciously positive/positive, compatible with CE/positive, independently with CE
18. Process after CE diagnosis
 i) Observation with assumption of benign condition/due to patient’s refusal to treat
 ii) Medication
 iii) Endoscopic treatment, EGD/colonoscopy/push enteroscopy/DBE
 iv) Surgery
 v) Follow up lost
 vi) Other
Adapted from Gut Image Study Group85
CE, capsule endoscopy; SB, small bowel; NSAID, non-steroidal anti-inflammatory drug; GI, gastrointestinal; CD, Crohn’s disease; CT, com-
puted tomography; MRE, magnetic resonance enterography; EGD, esophagogastroduodenoscopy; US, ultrasonography; DBE, double-bal-
loon enteroscopy; MRI, magnetic resonance imaging; PET, positron emission tomography; NPO, nothing per oral; PEG, polyethylene 
glycol.
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surgical removal of retained capsule could be reserved.
CE report
Procedure reports are required for every capsule endos-
copy and should be accurate, concise, and completed in a 
timely manner (grade of recommendation: 3).
Accurate and timely documentation of capsule endoscopic 
findings and recommendations improve patients care. The 
task force emphasizes that the CE report should be detailed. 
The patient’s medical history justifying the CE should be 
described. The indications are classified into signs and symp-
toms, and diseases. Standardization of the language and struc-
ture of endoscopic reports based on CE structured terminolo-
gy (CEST) may improve communication between clinicians.84 
To define the location of lesions more precisely, the temporal 
location should be defined by time points recorded by CE. 
The following locations can be detected by specific time-point 
of landmarks: time of ingestion, time of the first gastric image, 
time of the first duodenal image, and time of the first colonic 
image. For practical description, diagnoses are divided into 
main diagnoses and other diagnoses, which are less important 
or less associated with the reason for CE. Complications are 
described as unexpected events that occur during or after the 
CE. Minimal elements of a CE report are summarized in Ta-
ble 3.72,84,85
CONCLUSIONS
We expect that the outcome of SB CE can be improved by 
trying to meet the abovementioned 16 quality indicators. Im-
provement of the outcomes should be confirmed by following 
studies. Continuous process of quality improvement should 
be followed. 
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